CRM vs ORCL
CRM and ORCL side by side — valuation & fundamentals (public data).
Key statistics
| Metric | CRMSalesforce, Inc. | ORCLOracle Corporation |
|---|---|---|
| Market cap | $157.83B | $423.24B |
| P/E (TTM) | 22.3 | 25.2 |
| P/B | 4.61 | 9.96 |
| P/S | 3.8x | 6.3x |
| Dividend yield | 1.01% | 1.37% |
| Revenue | $42.83B(TTM) | $67.36B(TTM) |
| Revenue growth (YoY) | 9.6% | 17.3% |
| Net income | $8.02B(TTM) | $17.09B(TTM) |
| Earnings growth (YoY) | 20.3% | 37.3% |
| EPS, diluted | $8.63(TTM) | $5.83(TTM) |
| EBIT margin | 20.1% | 30.6% |
| ROE | 21.8% | 40.2% |
| ROIC | 10.1% | 90.5% |
| Piotroski F | 7/9 | — |
| 1y total return | -19.2% | -40.3% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: CRM frente a ORCL
| Métrica | CRM | ORCL |
|---|---|---|
| Valor final | $25.9K | $42.2K |
| Retorno total | +159.4% | +322.1% |
| CAGR | +9.7% | +14.9% |
| Volatilidad | 35.3% | 35.4% |
| Sharpe | 0.33 | 0.46 |
| Sortino | 0.47 | 0.71 |
| Caída máxima | -58.7% | -64.6% |
Basado en 2600 días de negociación comunes, 2016-04-06 → 2026-08-07 · tasa libre de riesgo 3.87% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)